Synthesis, antiproliferative and 4D-QSAR studies of thiadiazole derivatives bearing acrylamide moiety as EGFR inhibitors.
SAR QSAR Environ Res
; 34(4): 341-359, 2023 Apr.
Article
in En
| MEDLINE
| ID: mdl-37218662
ABSTRACT
As a target for clinical anti-cancer treatment, epidermal growth factor receptor (EGFR) exhibits its over-expression on various tumour cells and is associated with the development of a variety of human cancers. Herein, we described the synthesis, antiproliferative activity assay and 4D-QSAR studies of thiadiazole derivatives bearing acrylamide moiety as EGFR inhibitors. Compared with Gefitinib, some of the target compounds have excellent antiproliferative activities against EGFR-expressed A431 cell line. The robust and reliable 4D-QSAR was constructed using comparative distribution detection algorithm, ordered predictors selection and genetic algorithm method, and the following acceptable statistics are shown r2 = 0.82, Q2LOO = 0.67, Q2LMO = 0.61, r2Pred = 0.78.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quantitative Structure-Activity Relationship
/
ErbB Receptors
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
SAR QSAR Environ Res
Year:
2023
Document type:
Article